The 10X Genomics Xenium Analyzer will support true single cell spatial transcriptomics on fresh frozen or fixed tissue samples. You can characterize 100s to 1000s of RNAs in cells and tissues using ...

The 10X Genomics Xenium Analyzer will support true single cell spatial transcriptomics on fresh frozen or fixed tissue samples. You can characterize 100s to 1000s of RNAs in cells and tissues using ...

10x Genomics delivered strong Q4 2023 results with substantial contributions from Xenium and Visium platforms. As the company enters 2024, its focus on expanding product adoption while managing ...

At the Advances in Genome Biology and Technology, AGBT, General Meeting, 10x Genomics (TXG ... a robust new product roadmap ...

10x Genomics, Inc., a life science technology company ... analytes from standard glass slides to Visium slides; and Xenium Analyzer instrument enables researchers to detect and preserve the ...

10X Genomics Xenium platform, and the Vizgen Merscope system, which provide high-resolution spatial mapping of RNA within tissues. Epigenomics Core is a new CPRIT supported core facility that ...

Given this risk, we thought we'd take a look at whether 10x Genomics (NASDAQ:TXG) shareholders should be worried about its cash burn. In this report, we will consider the company's annual negative ...

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology and to advance human health. Cited in more than 7,000 research papers, ...

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the life sciences tools & services industry, including 10x Genomics (NASDAQ:TXG) and its peers.

Xenium is a powerful in situ gene expression platform designed for spatially resolving RNA transcripts (up to 5,000 genes) within tissue samples. It enables detailed mapping of gene activity at the ...